BioSpace News Archive

Pharm Country

CytoSorbents Comments on Bank Exposure and Diversified Cash Position

CytoSorbents Corporation announced that it does not have any direct financial exposure to Silicon Valley Bank or Signature Bank.

March 14, 2023
·
5 min read
Business

Axogen, Inc Reports 2022 Fourth Quarter and Full-Year Financial Results

Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today reported financial results and business highlights for the fourth quarter and full year ended December 31, 2022.

March 14, 2023
·
17 min read
Biotech Beach

NuVasive to Participate in Upcoming Spine Society Annual Conferences

NuVasive, Inc. today announced its continued participation at the 2023 Spine Summit held March 16-19 in Miami and the International Meeting on Advanced Spine Techniques.

March 14, 2023
·
3 min read
Business

COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2022 FULL YEAR FINANCIAL RESULTS AND CONFERENCE CALL INFORMATION

CollPlant Biotechnologies today announced that it will report financial results for the full year ended December 31, 2022, on March 29, 2023, before the market open.

March 14, 2023
·
2 min read
Exscientia Announces Expansion of its Precision Oncology Pipeline

Exscientia plc (Nasdaq: EXAI) today announced two new wholly-owned precision oncology development candidates, EXS74539 (‘539), an LSD1 inhibitor, and EXS73565 (‘565), a MALT1 protease inhibitor.

March 14, 2023
·
7 min read
Business

Ainos and Merdury Sign MoU to Explore Phase 3 Study of VELDONA Drug Candidate for Treatment of Oral Warts in HIV-Seropositive Patients

Ainos, Inc. today announced that it has signed a Memorandum of Understanding with Merdury Biopharmaceutical Corp., a Taipei Exchange Emerging Stock Board listed company (TPEx: Code 6932) (“Merdury”), to jointly explore and develop a strategic business relationship.

March 14, 2023
·
5 min read
Biotech Bay

Alterity Therapeutics Announces Granting of New Composition of Matter Patent and Exclusive License Agreement for Assets in Alzheimer’s Disease

Alterity Therapeutics today announced that the composition of matter patent previously allowed by the United States Patent and Trademark Office (USPTO) has now been granted.

March 14, 2023
·
6 min read
Biotech Beach

Reneo Pharmaceuticals Achieves Target Enrollment in the Pivotal STRIDE Study of Mavodelpar (REN001) in Primary Mitochondrial Myopathies

Reneo Pharmaceuticals, Inc. today announced that the company has achieved the target enrollment in the pivotal STRIDE study of mavodelpar (REN001) in primary mitochondrial myopathies (PMM).

March 14, 2023
·
4 min read
Genetown

BlueRock Therapeutics to incorporate wearable and invisible contactless digital health technologies from Rune Labs and Emerald Innovations in Parkinson’s disease clinical trial

BlueRock Therapeutics LP today announced a collaboration with Rune Labs and Emerald Innovations focused on using wearable and invisible contactless digital health technology to improve monitoring and data collection for Parkinson’s disease clinical trials.

March 14, 2023
·
9 min read
Business

BlueRock Therapeutics to use Rune Labs’ clinical trial platform to better characterize Parkinson’s disease state in cell therapy trials

Rune Labs today announced a partnership with BlueRock Therapeutics, a clinical stage biopharmaceutical company and wholly-owned, independently operated subsidiary of Bayer AG.

March 14, 2023
·
4 min read